Can a patient apply a combination of biestrogen (estrogen), progesterone, and testosterone to the face?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Facial Application of Compounded Hormone Creams

No, patients should not apply compounded biestrogen/progesterone/testosterone creams to the face. There is no evidence supporting facial application of these hormone combinations, and this practice carries significant risks including acne exacerbation, skin irritation, and unintended systemic absorption with potential adverse effects.

Why Facial Application Is Not Recommended

Lack of Evidence and Approval

  • No guidelines or FDA-approved formulations exist for applying compounded hormone combinations (biestrogen/progesterone/testosterone) to facial skin 1
  • Hormone replacement therapy formulations are designed for application to specific body sites (lower abdomen, upper buttocks, back, or upper arms) where absorption is predictable and controlled 2

Risk of Acne Development

  • Testosterone application to the face would likely worsen or trigger acne, as androgens are a primary driver of acne pathogenesis through increased sebum production and follicular hyperkeratinization 1
  • Hormonal acne treatment guidelines specifically recommend anti-androgenic therapies (like spironolactone or combined oral contraceptives), not topical androgens 1
  • The American Academy of Dermatology guidelines emphasize that hormonal agents for acne work by reducing androgen effects, not increasing them 1

Unpredictable Absorption and Safety Concerns

  • Facial skin has different absorption characteristics than approved application sites, leading to unpredictable systemic hormone levels 2, 3
  • Combined estrogen/progesterone therapy carries cardiovascular and thrombotic risks that increase with uncontrolled dosing 1, 2, 4
  • The face's rich vascular supply could lead to excessive systemic absorption compared to recommended application sites 2

Approved Application Sites for Transdermal Hormones

Correct Body Sites

  • Transdermal estradiol patches should be applied to clean, dry, intact skin on the lower abdomen, upper buttocks, back, or upper arms 2
  • These sites provide predictable absorption while avoiding areas with high sebaceous gland density (like the face) 2, 3

Why These Sites Are Chosen

  • Lower risk of skin irritation and acne development 2
  • More stable and predictable hormone absorption patterns 2
  • Avoidance of first-pass hepatic metabolism while maintaining controlled systemic delivery 2

Addressing Potential Motivations for Facial Application

If Goal Is Facial Rejuvenation

  • Facial hormone application is not an evidence-based anti-aging strategy 5
  • Comprehensive facial assessment should guide appropriate cosmetic interventions (topical retinoids, chemical peels, or procedural options), not hormone creams 5

If Goal Is Hormone Replacement

  • Use FDA-approved transdermal estradiol patches (50-100 μg daily) applied to approved body sites 2, 4
  • Combine with appropriate progesterone dosing (micronized progesterone 200 mg daily for 12-14 days per month for sequential regimens, or 100 mg daily for continuous regimens) 2, 4
  • Testosterone supplementation in women, when indicated, should be prescribed and monitored by specialists, not applied to facial skin 6, 7

Critical Safety Warnings

Contraindications to Consider

  • History of breast cancer or hormone-sensitive malignancies makes any hormone therapy inappropriate 1, 4
  • History of venous thromboembolism, stroke, or cardiovascular disease significantly increases risks with estrogen/progesterone therapy 1, 2
  • Active liver disease contraindicates hormone therapy 4

Monitoring Requirements

  • If hormone replacement is medically indicated, annual clinical review is required to assess compliance, side effects, and ongoing risk-benefit balance 2, 4
  • No routine laboratory monitoring is needed unless specific symptoms arise, but cardiovascular risk factors should be screened 2, 3

The Bottom Line

Compounded hormone creams should never be applied to the face. If the patient requires hormone replacement therapy, prescribe FDA-approved transdermal estradiol patches applied to the lower abdomen, buttocks, back, or upper arms, combined with appropriate oral progesterone dosing 2, 4. If facial skin concerns exist, address them with evidence-based dermatologic treatments, not hormone creams 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dosing of Transdermal Estrogen and Cyclic Progesterone After Progesterone Therapy Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Estradiol Patch Dosing for Feminizing Hormone Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lowest Dose of Progesterone for Hormone Replacement Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Facial assessments: identifying the suitable pathway to facial rejuvenation.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2006

Related Questions

What conditions and/or long-term medications cause low estrogen, progesterone, and testosterone levels?
Does the over-the-counter (OTC) progesterone pill improve symptoms of brain fog in perimenopausal women?
What is the effect of hormone replacement therapy (HRT) patch on Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) levels?
What hormones should be checked in a 47-year-old female?
What is the recommended treatment for a 47-year-old female with elevated Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) levels, low progesterone, thrombocytosis, and impaired glucose regulation, as indicated by a Hemoglobin A1c (HgA1c) level of 5.9 and estrogen level of 25.9?
What are the pharmacokinetics and pharmacodynamics of metamizol?
Should all patients with high-risk endometrial cancer, including those with stage 1 grade 3 disease, lymphovascular space invasion (LVSI), and deep myometrial invasion, receive concurrent external beam radiation therapy (EBRT) followed by adjuvant chemotherapy, similar to those with stage 3, serous, or p53 positive tumors?
Can clotrimazole be used in combination with zinc oxide ointment for a patient with a fungal skin infection?
What is the diagnosis and treatment approach for a child with diabetes insipidus?
What should be included in a 30-slide PowerPoint presentation on headache for medical students?
What is the initial treatment for a patient diagnosed with Streptococcal pneumonia, considering potential severity and no severe allergies to penicillin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.